NDC 71332-005 – Rezlidhia

Olutasidenib 150 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71332-005

Product details

Brand name
Rezlidhia
Generic name
Olutasidenib
Labeler
Rigel Pharmaceuticals, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA215814
Marketed since
December 1, 2022
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Rezlidhia →

Package NDC codes (1)

Package NDCDescriptionSince
71332-005-0130 CAPSULE in 1 BOTTLE (71332-005-01)Dec 1, 2022